成中的认知功能障碍 (CDiA):一个神经到邻居协作研究项目,研究行政功能障碍和外科医生寻求成治疗的功能结果
Yuliya S Nikolova1,2,3, Anthony C Ruocco1,2,3,4, Daniel Felsky1,2,5
1Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
medRxiv : the preprint server for health sciences
|September 10, 2024
概括
这项研究计划调查了物质使用障碍 (SUDs) 中的认知功能障碍,探索执行功能 (EFs) 以及它们与神经回路,生物标志物和恢复的联系. 这些发现旨在通过了解SUD中的EF来改善成治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 药物使用障碍 (SUD) 是一个主要的全球健康问题.
- 执行功能 (EF) 在成模型中至关重要,但它们在SUD中的作用需要进一步研究.
- 在了解EF与神经回路,生物标志物,疾病异质性和SUD功能能力的关系方面存在差距.
研究的目的:
- 引入认知功能障碍在成 (CDiA) 计划中的认知功能障碍,一个整合性研究倡议.
- 解决SUD内部EF的知识差距.
- 促进研究发现,以改善SUD患者的治疗方法.
主要方法:
- 该CDiA计划包括七个跨学科项目,其中包括对400名成年人 (18-60岁) 进行前性研究,这些成年人在一年内寻求成治疗.
- 项目调查SUDs,大脑电路,血液生物标志物,EFs (抑制,工作记忆,设置转换) 和功能结果.
- 使用干预措施 (rTMS,临床前药理学),医疗保健利用和机器学习的全人建模.
主要成果:
- 该计划整合了各种数据,以揭示EF,SUD严重程度和功能恢复之间的联系.
- 调查结果来自临床,临床前,卫生服务和全人建模调查.
- 这项研究旨在增强对成中认知功能障碍的理解.
结论:
- 预计CDiA计划将推进对SUDs EFs的科学理解.
- 这些发现将为SUD患者的未来临床护理和治疗策略提供信息.
- 这个倡议将多个科学领域联系在一起,以改善成患者的治疗结果.
相关概念视频
Substance Use Disorders Affecting Sleep
162
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
162
Attention-Deficit/Hyperactivity Disorder
50
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
50
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
108
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
108
Drug Abuse and Addiction: Pharmacological Phenomena
448
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
448
CNS Depressants: Alcohol and Nicotine
181
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
181
Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452


